Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.
about
Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
P2860
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy of two different dose ...... ed, open-label, phase 3 trial.
@en
type
label
Efficacy of two different dose ...... ed, open-label, phase 3 trial.
@en
prefLabel
Efficacy of two different dose ...... ed, open-label, phase 3 trial.
@en
P2093
P50
P921
P1433
P1476
Efficacy of two different dose ...... ed, open-label, phase 3 trial.
@en
P2093
Alice Bertaina
Arcangelo Prete
Attilio Rovelli
Claudio Favre
Daria Pagliara
Edoardo Lanino
Franca Fagioli
Franco Locatelli
Giovanna Giorgiani
Maria Ester Bernardo
P304
P356
10.1016/S1470-2045(17)30417-5
P577
2017-07-10T00:00:00Z